{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.136","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:16.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.136","version":"20210306","name":"Dolasetron Injectable","status":"active","date":"2021-03-06T01:00:16-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1790812","display":"0.625 ML dolasetron mesylate 20 MG/ML Injection"},{"code":"1790818","display":"5 ML dolasetron mesylate 20 MG/ML Injection"},{"code":"200101","display":"dolasetron mesylate 20 MG/ML Injectable Solution"}]}]}}